GLYCTK

protein-coding

glycerate kinase

Gene summary

This locus encodes a member of the glycerate kinase type-2 family. The encoded enzyme catalyzes the phosphorylation of (R)-glycerate and may be involved in serine degradation and fructose metabolism. Decreased activity of the encoded enzyme may be associated with the disease D-glyceric aciduria. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jan 2009]

MANE transcript

NM_145262.4

Inheritance

AR

ClinVar variants

P:9U:141B:74

Top phenotype

D-glyceric aciduria

gnomAD constraint

pLI —, LoF o/e 1.05

Max pathogenic AF

—

Genomic locus

chr3:52,287,089-52,295,257

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~8.2 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

D-glyceric aciduriaMODERATE

Inheritance Pattern: AR

Disease ID:MONDO:0009070

Submitter: ClinGen

Autosomal recessive D-glyceric aciduria was first reported in 1974 (Brandt NJ et al., PMID: 4434100); however, the causative gene and variant were not identified until 2010 (Sass JO et al., PMID: 20949629). Several patients have been described in the literature, the majority based primarily on biochemical findings without accompanying genomic data. The reported clinical spectrum is highly variable, ranging from severe, progressive infantile encephalopathy to a nearly asymptomatic condition. Subsequent investigations have provided additional insights into the etiology of symptoms described in earlier reports. For example, Swanson MA et al. (PMID: 28462797) demonstrated that the nonketotic hyperglycinemia phenotype reported by Brandt NJ et al. (PMID: 4434100) and Sass JO et al. (PMID: 20949629) was attributable to a homozygous missense variant in *AMT* (c.350C>T; p.Ser117Leu). Similarly, Kingma SDK et al. (PMID: 39619776) reported a patient whose hearing loss was attributed to a homozygous pathogenic variant in *STRC* (c.4837G>T; p.Glu1613*). These findings make it unclear whether the clinical features described across reports represent a consistent phenotype attributable to *GLYCTK*, or whether they were influenced by additional genomic findings that were not assessed in earlier studies. The most consistent phenotypic feature curated for this disease entity is the accumulation of D-glycerate in urine, and in some cases serum and cerebrospinal fluid, detected by urine organic acid analysis. To date, four variants (all frameshift) have been reported across three publications (PMID: 4434100; PMID: 20949629; PMID: 39619776) and are included in this curation. The proposed disease mechanism is loss of function, supported by in vitro functional expression studies in HEK293 cells demonstrating that mutant proteins were not expressed and lacked enzymatic activity (Sass JO et al., PMID: 20949629). In summary, there is moderate evidence supporting a gene–disease relationship between *GLYCTK* and autosomal recessive D-glyceric aciduria. This classification was approved by the ClinGen IEM GCEP at the meeting on December 12, 2025 (SOP Version 11).

D-glyceric aciduriaSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0009070

Submitter: PanelApp Australia

D-glyceric aciduriaSUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0009070

Submitter: Orphanet

D-glyceric aciduriaSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0009070

Submitter: Labcorp Genetics (formerly Invitae)

Clinical Genomic Database (CGD)

D-glyceric aciduriaAR

Manifestation: Biochemical; Neurologic

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Refs: 4599249; 2537226; 20949620Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to GLYCTK variants in ClinVar

4 Conditions Cataloged
not providedTotal: 145
not specifiedTotal: 101
D-Glyceric aciduriaTotal: 22
GLYCTK-related disorderTotal: 12

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_145262.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
1
clinvar
59
clinvar
3
clinvar
64
missense
1
clinvar
134
clinvar
10
clinvar
2
clinvar
147
nonsense
1
clinvar
1
clinvar
2
start loss
0
frameshift
3
clinvar
3
clinvar
5
clinvar
11
splice donor/acceptor (+/-2bp)
0
Total36141695224

Highest pathogenic variant AF is 0.00010161078

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 32 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_145262.4RefSeqNP_660305.24MANE Select
ENST00000436784.7EnsemblENSP00000389175.24MANE Select
NM_001144951.2RefSeqNP_001138423.13Standard
NM_001437621.1RefSeqNP_001424550.14Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Glycerolipid metabolism - Homo sapiens (human)
  • Glycine, serine and threonine metabolism - Homo sapiens (human)
  • Pentose phosphate pathway - Homo sapiens (human)
  • Glyoxylate and dicarboxylate metabolism - Homo sapiens (human)
  • 3-Phosphoglycerate dehydrogenase deficiency

Biological Process

  • protein phosphorylation
  • fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate

Molecular Function

  • protein binding
  • ATP binding
  • glycerate kinase activity

Cellular Component

  • cytoplasm
  • mitochondrion
  • Golgi apparatus
  • cytosol

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000436784
Coding exons
4
Length
8168
Individuals with no LoFs
125681
Homozygous LoFs
0
Heterozygous LoFs
61
Defined
125742
p
0.000243
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense-0.2283333221.040.00002003298
Missense (PolyPhen)8483.2881.0086906
Synonymous-0.5021471391.050.000007771232
Loss of Function-0.1711514.31.056.14e-7154

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000310.00031rare
Latino/Admixed American0.000610.00061rare
Ashkenazi Jewish00.0absent
East Asian0.000110.00011rare
Finnish0.0000470.000046rare
European (Non-Finnish)0.000210.00021rare
South Asian0.000260.00026rare
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Recessive Scores

pRec
0.186

Intolerance Scores

LoFtool
0.810
RVIS EVS
0.24
RVIS percentile EVS
69.46

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.766

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.